- Home
- /
- Treatment
- /
- Page 5
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
Bitopertin | Beta-thalassaemia intermedia and major | Roche Registration Limited | October 16, 2017 | |
Cannabidivarin | Rett syndrome | GW Research Ltd | October 16, 2017 | |
Glucopyranosyl lipid A | Follicular lymphoma | Immune Design Ltd | October 16, 2017 | |
Humanised monoclonal antibody targeting B-cell maturation antigen conjugated with maleimidocaproyl monomethyl auristatin F | Multiple myeloma | GlaxoSmithKline Trading Services Limited | October 16, 2017 | |
Ofranergene obadenovec | Ovarian cancer | Envigo Pharma Consulting Ltd | October 16, 2017 | |
Recombinant adeno-associated viral vector serotype 5 encodingStaphylococcus aureusCas9 endonuclease and two guide RNAs complementary to two regions of intron 26 of theCEP290gene | Leber congenital amaurosis | Pharma Gateway AB | October 16, 2017 | |
Autologous human peripheral blood mononuclear cells incubated ex vivo with protein TBX-4000 (Tat-MYC) | Malignant melanoma Stages IIb to IV | Taiga Biotechnologies, Inc.;12635 Montview Boulevard, Fitzsimmons BBioscience Park Center;Aurora, Colorado, 80045 | October 16, 2017 | |
Entospletinib | Acute myeloid leukaemia | Gilead Sciences International Ltd. | October 16, 2017 | |
Seladelpar | Primary biliary cirrhosis | Larode Ltd | October 16, 2017 | |
Glasdegib maleate | Acute myeloid leukaemia | Pfizer Limited | October 16, 2017 | |
Synthetic cyclic 8 amino acid analogue of human unacylated ghrelin | Prader-Willi syndrome | Alizé Pharma | October 16, 2017 | |
Pracinostat | Acute myeloid leukaemia | Helsinn Birex Pharmaceuticals Ltd | October 16, 2017 | |
Synthetic cyclic 8 amino acid analog of human unacylated ghrelin | Prader-Willi syndrome | Aliz� Pharma;15G Chemin du Saquin;�cully | October 12, 2017 | |
Autologous glioma tumor cells treated with 18-mer oligodeoxynucleotide sequence complementary to insulin-like growth factor type 1 receptor (IGF-1R) codons 2-7 in the IG-1R gene | Glioma | Thomas Jefferson University;Department of Neurological Surgery, 909 Walnut Street;Philadelphia, Pennsylvania, 19107 | October 11, 2017 | |
Avelumab | Stomach Cancer | EMD Serono Research & Development Institute, Inc.;45A Middlesex Turnpike;Billerica, Massachusetts, 01821 | October 11, 2017 | |
Autologous T lymphocyte enriched population cultured in the rpesence of phosphatidylinositol 3-kinase inhibitor (bb007) that contains cells transduced with an anti-human B cell maturation antigen (BCMA02) chimeric antigen receptor (CAR) lentiviral vector encoding a CAR that targets human BCMA | Multiple myeloma | bluebird bio, Inc.;60 Binney Street;Cambridge, Massachusetts, 02142 | October 5, 2017 | |
Filgotinib maleate | Ulcerative colitis | Gilead Sciences, Inc.;199 E. Blaine St.;Seattle, Washington, 98102 | October 5, 2017 | |
(2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide-methane sulfonic acid salt) | Graft Versus Host Disease | Kadmon Corporation, LLC;450 East 29th Street;New York, New York, 10016 | October 5, 2017 | |
6-{[(1R,2S)-2-aminocyclohexyl]amino}-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one monocitrate | Acute myeloid leukemia | Millennium Pharmaceuticals, Inc.;40 Landsdowne Street;Cambridge, Massachusetts, 02139 | October 3, 2017 | |
Adeno Associated Virus carried Multi Characteristic Opsin | Retinitis pigmentosa | NanoScope Technologies;1312 Brown Trail;Bedford, Texas, 76022 | October 3, 2017 | |
Gaboxadol | Fragile X syndrome | Ovid Therapeutics;1460 Broadway;New York, New York, 10036 | October 3, 2017 | |
Pembrolizumab | Small Cell Lung Cancer excluding those that have been identified as having a biomarker referred to as microsatellite instability-high (MSI-H) or mismatched repair deficient (dMMR) | Merck, Sharp, & Dohme, a subsidiary of Merck & Co., Inc.;1 Merck Drive;Whitehouse Station, New Jersey, 08889 | October 3, 2017 | |
1-(2-hydroxyethyl)-8-{[5-(4-methylpiperazin-1-yl)-2-(trifluoromethoxy) phenyl]amino}-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide fumarate salt | Acute myeloid leukemia | Trovagene, Inc.;11055 Flintkote Avenue;San Diego, California, 92121 | September 28, 2017 | |
Autologous CD4+/CD8+ T cells expressing a BCMA-specific chimeric antigen receptor (CAR) | Multiple myeloma | Juno Therapeutics, Inc.;400 Dexter Avenue North, Suite 1200;Seattle, Washington, 98109 | September 28, 2017 | |
Givinostat | Polycythemia vera | Italfarmaco SpA;54 Via dei Lavoratori;Cinisello Balsamo | September 28, 2017 |